Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one

By Hurwitz J.L.   Soike K.F.   Sangster M.Y.   Portner A.   Sealy R.E.   Dawson D.H.   Coleclough C.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 533-540

Elsevier

Access to resources Recommend Favorite

Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine

By Fouts T.R.   Lewis G.K.   Hone D.M.  

Vaccine, Vol. 13, Iss. 6, 1995-04 ,pp. : 561-569

Elsevier

Access to resources Recommend Favorite

Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection

By Gorse G.J.   Patel G.B.   Arbuckle J.A.   Belshe R.B.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 383-397

Elsevier

Access to resources Recommend Favorite

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

By Gorse G.J.   Patel G.B.   Mandava M.D.   Belshe R.B.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 835-849

Elsevier

Access to resources Recommend Favorite

Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine

By Boursaux-Eude C.   Thiberge S.   Carletti G.   Guiso N.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2651-2660

Elsevier

Access to resources Recommend Favorite